Johnson & Johnson’s Tremfya may have debuted behind Novartis' Cosentyx, but it has now topped the blockbuster in a head-to-head trial.

​​​​​​​AbbVie is pushing its time-to-cure advantage in new ads for hepatitis C treatment Mavyret that emphasize a cure “in only 8 weeks.”

With an FDA safety review in the rearview mirror, Acadia is back to business on Nuplazid—and launching its first branded ad campaign to boot.

For the second straight year, AstraZeneca is spending the fall launching a hemo-oncology drug.

Merz Americas hopes to grab cosmetic injection share with two new ad campaigns that push awareness of options other than market leader Botox.

Klick Health debuts its annual holiday video with an imaginary launch of a new agency called Klickmas, the world’s first all-Christmas agency.

Cannes Lions Health last week named the two jury chiefs set to oversee advertising awards in health & wellness and pharma.

AstraZeneca is still stinging from Imfinzi’s combo flop in non-small cell lung cancer, but it’s already staring down another defeat.